September 22, 2026 | ASCO, Congress, Pharma, healthcare, oncology
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

The pace of innovation in oncology is accelerating, bringing more data, more complex science, and more information for HCPs to navigate.
Our latest oncology congress eBook explores what this means for life sciences organizations and how congress experiences can help turn scientific innovation into understanding.
Discover insights on:
Making meaningful connections in an age of accelerated innovation
Creating more effective congress experiences
The future of congress engagement for life sciences companies
Emerging trends shaping oncology commercialization
Why a connected approach is key to congress success
This content was provided by Inizio
Latest Content from Inizio
Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have been crowned Specialist Consultancy of the Year at this week’s prestigious PR Week Awards. The accolade tops…
Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,…
Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to…
Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients…
The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.
A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public…
The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space…
Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain…
We look for bright and inquisitive people who want to learn in a company that’s pushing the boundaries of pharmaceutical market research
Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the prestigious Consultancy of the Year award at the 2016 Communiqué Awards in London. The judges…
